Differentiation Therapy with Progesterone Antagonists-Reference-Cited by-同舟云学术

Differentiation Therapy with Progesterone Antagonists

Published:1995-06 Issue:1 Volume:761 Page:224-247
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:

Author:

MICHNA HORST,PARCZYK KARSTEN,SCHNEIDER MARTIN R.,NISHINO YUKISHIGE

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.1995.tb31381.x/fullpdf

Reference149 articles.

1. Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, antiestrogen and progesterone;Mobbs;Cancer Res,1987

2. Quantitation of cytosolic and nuclear estrogen and progesterone receptors in benign, untreated and treated malignant human prostatic tissue by radioligand binding and enzyme immunoassays;Mobbs;Prostate,1990

3. Immunohistochemical localization of progesterone receptor in benign and malignant prostate tissue;Mobbs;Prostate,1990

4. Regio and stereospecific synthesis of 11β-substituted 19-norsteroids;Teutsch;J. Steroid. Biochem.,1978

5. RU 486: a potent antiglucocorticoid in vivo;Philibert;VIII Int. Congr. of Pharmacology. Toronto.,1981

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, molecular docking, and biological studies of novel phytoestrogen-tanaproget hybrids;Synthetic Communications;2016-03-03

2. 6-Arylcoumarins as Novel Nonsteroidal Type Progesterone Antagonists: An Example with Receptor-Binding-Dependent Fluorescence;Journal of Medicinal Chemistry;2011-10-05

3. Synthesis and SAR study of novel pseudo-steroids as potent and selective progesterone receptor antagonists;Bioorganic & Medicinal Chemistry Letters;2009-07

4. Insight from molecular modeling into different conformation and SAR of natural steroids and unnatural 7-oxa-steroids;Bioorganic & Medicinal Chemistry Letters;2008-07

5. Investigational developments for the treatment of progesterone-dependent diseases;Expert Opinion on Investigational Drugs;2008-03-25